Jefferies Financial Group Inc. Coherus Bio Sciences, Inc. Transaction History
Jefferies Financial Group Inc.
- $13.5 Billion
- Q3 2024
A detailed history of Jefferies Financial Group Inc. transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Jefferies Financial Group Inc. holds 282,625 shares of CHRS stock, worth $333,497. This represents 0.0% of its overall portfolio holdings.
Number of Shares
282,625
Previous 196,625
43.74%
Holding current value
$333,497
Previous $340,000
13.82%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CHRS
# of Institutions
132Shares Held
76.9MCall Options Held
40.7KPut Options Held
50.1K-
Black Rock Inc. New York, NY11.8MShares$13.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$13.3 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.4MShares$12.3 Million0.3% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY3.04MShares$3.58 Million0.18% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.86MShares$3.37 Million0.0% of portfolio
About Coherus BioSciences, Inc.
- Ticker CHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,724,600
- Market Cap $91.7M
- Description
- Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...